Health Care & Life Sciences » Pharmaceuticals | Jilin Zixin Pharmaceutical Industrial Co. Ltd.

Jilin Zixin Pharmaceutical Industrial Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
470
770
627
806
1,306
1,300
Cost of Goods Sold (COGS) incl. D&A
147
379
249
254
326
534
Gross Income
323
391
378
551
979
766
SG&A Expense
201
240
232
237
365
333
EBIT
122
144
138
341
614
432
Non Operating Income/Expense
6
8
10
14
20
25
Interest Expense
91
137
140
157
198
245
Pretax Income
54
46
44
200
438
212
Income Tax
4
1
5
37
67
38
Consolidated Net Income
50
47
39
163
371
174
Net Income
50
47
40
163
372
174
Net Income After Extraordinaries
50
47
40
163
372
174
Net Income Available to Common
50
47
40
163
372
174
EPS (Basic)
0.05
0.05
0.04
0.13
0.29
0.14
Basic Shares Outstanding
1,026
1,026
1,026
1,255
1,281
1,281
EPS (Diluted)
0.05
0.05
0.04
0.13
0.29
0.14
Diluted Shares Outstanding
1,026
1,026
1,026
1,255
1,281
1,281
EBITDA
164
204
206
411
717
537
Other Operating Expense
-
7
8
27
1
-
Non-Operating Interest Income
-
-
1
1
2
-
Minority Interest Expense
-
-
-
-
-
-

About Jilin Zixin Pharmaceutical Industrial Co.

View Profile
Address
No. 137 Dongtoudao Street
Changchun Jilin 130041
China
Employees -
Website http://www.jilinzixin.com.cn
Updated 07/08/2019
Jilin Zixin Pharmaceutical Industrial Co., Ltd. engages in the research, development, manufacture, and sale of herbal medicines. Its medicine offers treatment for cardiovascular and cerebrovascular diseases, digestive system diseases, and bone fracture. The company was founded on May 25, 1998 and is headquartered in Changchun, China.